v3.26.3
Segments (Tables)
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Research and Development Expenses The following table summarizes our research and development expenses for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Nonclinical expenses$385 $184 $1,025 $445 
Clinical expenses2,220 7,250 11,564 18,315 
CMC expenses7,736 2,556 16,930 7,802 
License and milestone expenses— — 10,000 — 
Internal expenses:
Salaries, benefits and related costs2,825 2,383 8,040 6,414 
Stock-based compensation expense1,791 1,189 4,714 3,606 
Other89 59 239 235 
$15,046 $13,621 $52,512 $36,817